An Interleukin-6 Receptor Polymorphism is Associated with Opisthorchiasis-Linked Cholangiocarcinoma Risk in Thailand |
Prayong, Pokpong
(Department of Pathology, Faculty of Medicine, Khon Kaen University)
Mairiang, Eimorn (Department of Radiology, Faculty of Medicine, Khon Kaen University) Pairojkul, Chawalit (Department of Pathology, Faculty of Medicine, Khon Kaen University) Chamgramol, Yaovalux (Department of Pathology, Faculty of Medicine, Khon Kaen University) Mairiang, Pisaln (Department of Medicine, Faculty of Medicine, Khon Kaen University) Bhudisawasdi, Vajarabhongsa (Department of Surgery, Faculty of Medicine, Khon Kaen University) Sripa, Banchob (Department of Pathology, Faculty of Medicine, Khon Kaen University) |
1 | Subrungruanga I, Thawornkunob C, Chawalitchewinkoon-Petmitrc P, et al (2013). Gene expression profiling of intrahepatic cholangiocarcinoma. Asian Pac J Cancer Prev, 14, 557-63. 과학기술학회마을 DOI ScienceOn |
2 | Wang H, Zhang Z, Chu W, et al (2005). Molecular screening and association analyses of the interleukin 6 receptor gene variants with type 2 diabetes, diabetic nephropathy, and insulin sensitivity. J Clin Endocrinol Metab, 90, 1123-9. DOI |
3 | Wise C, Pilanthananond M, Perry BF, et al (2008). Mechanisms of biliary carcinogenesis and growth. World J Gastroenterol, 14, 2986-9. DOI ScienceOn |
4 | Wu CW, Wang SR, Chao MF, et al (1996). Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol, 91, 1417-22. |
5 | Wu Q, He XD, Yu L, et al (2012). The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China. Asian Pac J Cancer Prev, 13, 1963-9. 과학기술학회마을 DOI ScienceOn |
6 | Shin HR, Oh JK, Masuyer E, et al (2010). Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma--focus on East and South-Eastern Asia. Asian Pac J Cancer Prev, 11, 1159-66. |
7 | Park J, Tadlock L, Gores GJ, et al (1999). Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology, 30, 1128-33. DOI ScienceOn |
8 | Qi L, Rifai N, Hu FB (2007). Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U.S. Women. Diabetes, 56, 3075-81. DOI ScienceOn |
9 | Reich D, Patterson N, Ramesh V, et al (2007). Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am J Hum Genet, 80, 716-26. DOI ScienceOn |
10 | Sripa B, Brindley PJ, Mulvenna J, et al (2012a). The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer. Trends Parasitol, 28, 395-407. DOI ScienceOn |
11 | Sripa B, Kaewkes S, Sithithaworn P, et al (2007). Liver fluke induces cholangiocarcinoma. PLoS Med, 4, e201. DOI |
12 | Sripa B, Mairiang E, Thinkhamrop B, et al (2009). Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6. Hepatology, 50, 1273-81. |
13 | Sripa B, Pairojkul C (2008). Cholangiocarcinoma: lessons from Thailand. Cur Opin Gastroenterol, 24, 349-56. DOI ScienceOn |
14 | Sripa B, Thinkhamrop B, Mairiang E, et al (2012b). Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini. PLoS Negl Trop Dis, 6, e1654. DOI |
15 | Malhi H, Gores GJ (2006). Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol, 45, 856-67. DOI ScienceOn |
16 | Kim LH, Lee HS, Kim YJ, et al (2003). Identification of novel SNPs in the interleukin 6 receptor gene (IL6R). Hum Mutat, 21, 450-1. |
17 | Lamas JR, Rodriguez-Rodriguez L, Varade J, et al (2010). Influence of IL6R rs8192284 polymorphism status in disease activity in rheumatoid arthritis. J Rheumatol, 37, 1579-81. DOI |
18 | Mairiang E, Laha T, Bethony JM, et al (2012). Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand. Parasitol Int, 61, 208-11. DOI ScienceOn |
19 | Marinou I, Walters K, Winfield J, et al (2010). A gain of function polymorphism in the interleukin 6 receptor influences RA susceptibility. Ann Rheum Dis, 69, 1191-4. DOI ScienceOn |
20 | Manwong M, Songserm N, Promthet S, et al (2013). Risk factors for cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study. Asian Pac J Cancer Prev, 14, 5953-6. 과학기술학회마을 DOI ScienceOn |
21 | Matsumoto K, Onoyama T, Kawata S, et al (2014). Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma. Intern Med, 53, 651-4. DOI |
22 | Mullberg J, Schooltink H, Stoyan T, et al (1993). The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol, 23, 473-80. DOI ScienceOn |
23 | Ninlawan K, O'Hara SP, Splinter PL, et al (2010). Opisthorchis viverrini excretory/secretory products induce Toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte. Parasitol Int, 59, 616-21. DOI ScienceOn |
24 | Gu F, Qureshi AA, Niu T, et al (2008). Interleukin and interleukin receptor gene polymorphisms and susceptibility to melanoma. Melanoma Res, 18, 330-5. DOI ScienceOn |
25 | Galicia JC, Tai H, Komatsu Y, et al (2006). Interleukin-6 receptor gene polymorphisms and periodontitis in a non-smoking Japanese population. J Clin Periodontol, 33, 704-9. DOI ScienceOn |
26 | Galicia JC, Tai H, Komatsu Y, et al (2004). Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced. Genes Immun, 5, 513-6. DOI ScienceOn |
27 | Hull J, Campino S, Rowlands K, et al (2007). Identification of common genetic variation that modulates alternative splicing. PLoS Genet, 3, 99. DOI ScienceOn |
28 | Goydos JS, Brumfield AM, Frezza E, et al (1998). Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker. Ann Surg, 227, 398-404. DOI ScienceOn |
29 | Heinrich PC, Behrmann I, Muller-Newen G, et al (1998). Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J, 334, 297-314. DOI |
30 | Huai JP, Ding J, Ye XH, et al (2014). Inflammatory bowel disease and risk of cholangiocarcinoma: evidence from a meta-analysis of population-based studies. Asian Pac J Cancer Prev, 15, 3477-82. 과학기술학회마을 DOI ScienceOn |
31 | IARC (1994). Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus and Clonorchis sinensis). IARC Monogr Eval Carcinog Risks Hum, 61, 121-75. |
32 | Jiang CQ, Lam TH, Liu B, et al (2010). Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD. Obesity, 18, 1969-74. DOI ScienceOn |
33 | Dosquet C, Schaetz A, Faucher C, et al (1994), Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma. Eur J Cancer, 30, 162-7. DOI ScienceOn |
34 | Blechacz B, Gores GJ (2008). Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology, 48, 308-21. |
35 | Bouvard V, Baan R, Straif K, et al (2009). A review of human carcinogens--Part B: biological agents. Lancet Oncol, 10, 321-2. DOI ScienceOn |
36 | Mullberg J, Oberthur W, Lottspeich F, et al (1994). The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. J Immunol, 152, 4958-68. |
37 | Bustamante M, Nogues X, Mellibovsky L, et al (2007). Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women. Eur J Endocrinol, 157, 677-84. DOI ScienceOn |
38 | Okada S, Okusaka T, Ishii H, et al (1998). Elevated serum interleukin-6 levels in patients with pancreatic cancer. Jpn J Clin Oncol, 28, 12-5. DOI ScienceOn |
39 | Heinrich PC, Behrmann I, Haan S, et al (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J, 374, 1-20. DOI ScienceOn |
40 | Esteve E, Villuendas G, Mallolas J, et al (2006). Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clin Endocrinol, 65, 88-91. DOI ScienceOn |
![]() |